Support By : Li-lab
| PATHWAY_NAME | REACTOME_ID | KEGG_ID | DRUG_NAME | PUBCHEM_CID | Datasource |
|---|---|---|---|---|---|
| Neuroactive ligand-receptor interaction | R-HSA-5632681 | map04080 | levodopa | 6047 | drug-path |
| Hedgehog signaling pathway | R-HSA-5358351 | map04340 | doxylamine | 3162 | drug-path |
| TGF-beta signaling pathway | R-HSA-168638 | map04350 | doxylamine | 3162 | drug-path |
| Olfactory transduction | R-HSA-9751605 | map04740 | doxylamine | 3162 | drug-path |
| Ribosome | R-HSA-5368277 | map03010 | doxylamine | 3162 | drug-path |
| Calcium signaling pathway | R-HSA-381753 | map04020 | doxylamine | 3162 | drug-path |
| Graft-versus-host disease | R-HSA-1643685 | map05332 | troleandomycin | 275196 | drug-path |
| Hematopoietic cell lineage | R-HSA-173752 | map04640 | troleandomycin | 275196 | drug-path |
| Autoimmune thyroid disease | R-HSA-1643685 | map05320 | troleandomycin | 275196 | drug-path |
| Antigen processing and presentation | R-HSA-1236975 | map04612 | troleandomycin | 275196 | drug-path |
| Cell adhesion molecules (CAMs) | R-HSA-1031690 | 0 | troleandomycin | 275196 | drug-path |
| Systemic lupus erythematosus | R-HSA-977105 | map05322 | troleandomycin | 275196 | drug-path |
| Asthma | R-HSA-444620 | map05310 | troleandomycin | 275196 | drug-path |
| Allograft rejection | R-HSA-9679028 | map05330 | troleandomycin | 275196 | drug-path |
| Type I diabetes mellitus | R-HSA-5683209 | map04940 | troleandomycin | 275196 | drug-path |
| Renal cell carcinoma | R-HSA-9794523 | map05211 | troleandomycin | 275196 | drug-path |
| Circadian rhythm - mammal | R-HSA-400253 | 0 | troleandomycin | 275196 | drug-path |
| Regulation of actin cytoskeleton | R-HSA-392751 | map04810 | troleandomycin | 275196 | drug-path |
| Colorectal cancer | R-HSA-4791275 | map05210 | troleandomycin | 275196 | drug-path |
| Graft-versus-host disease | R-HSA-1643685 | map05332 | naphazoline | 4436 | drug-path |